objectives transforming growth factor beta1 potent immunosuppressive cytokine promotes fibrosis enhancing synthesis extracellular matrix components repair process following lung allograft injury rejection infection replaces lung parenchyma fibrotic tissue leading pulmonary dysfunction role excessive healing process increasing risk infection unknown methods analysed patient data investigate relevance different factors allograft fibrosis correlation fibrosis graded h e stained sections genotype determined patients results patients aged NUMBER NUMBER years mean age NUMBER years procedures n NUMBER double lung n NUMBER slt n NUMBER total NUMBER patients lung allograft fibrosis diagnosed transbronchial biopsies sections patients developed interstitial fibrosis significantly acute rejection episodes mean NUMBER NUMBER compared patients fibrosis mean NUMBER NUMBER p NUMBER presence eosinophils interstitium preceded associated development fibrosis regardless rejection grade p NUMBER heavily expressed sections fibrosis mean score NUMBER NUMBER compared NUMBER NUMBER sections fibrosis p NUMBER expression correlated positively fibrosis grades p NUMBER mean survival patients fibrosis score NUMBER NUMBER NUMBER days compared mean survival NUMBER NUMBER patients scores NUMBER p NUMBER patients developed fibrosis homozygous genotype correlates excessive expression p NUMBER use cardiopulmonary bypass associated development excessive fibrosis p NUMBER NUMBER patients severe fibrosis died septicaemia NUMBER fev1 forced expiratory volume significantly higher patients fibrosis NUMBER NUMBER ml versus NUMBER NUMBER p NUMBER conclusions risks lung allograft fibrosis increases recurrent rejection tissue eosinophilia homozygous genotype use bypass machine fibrosis associated higher mortality morbidity explained immunosuppressive fibrotic properties immunological strategies tgfbeta1 production improve survival function lung allografts tgf beta1 tgf beta1 tgf beta1 tgf beta1 tgf beta1 tgf beta1 tgf beta1 tgf beta1 tgf beta1 tgf beta1 regulate heart lung